Alliance Pharma PLC Exercise of Share Options (8472O)

TIDMAPH

RNS Number : 8472O

Alliance Pharma PLC

01 June 2015

 
 For immediate release   1 June 2015 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Exercise of Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a further 248,650 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM.

It is expected that these new Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares, will be admitted to trading on 5 June 2015.

After Admission, Alliance will have 264,447,814 Ordinary Shares in issue.

For further information:

 
 Alliance Pharma plc             + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 
                                     + 44 (0) 20 7466 
 Buchanan                                        5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                     + 44 (0) 20 7260 
 Numis Securities Limited                        1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: David 
  Poutney 
 

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFLSRSILIIE